<html xmlns="http://www.w3.org/1999/xhtml" xmlns="http://www.w3.org/1999/xhtml">
 <head xmlns="http://www.w3.org/1999/xhtml">
 <title xmlns="http://www.w3.org/1999/xhtml"></title>
 </head>
 <body xmlns="http://www.w3.org/1999/xhtml">
 
 Bragar Eagel &amp; Squire, P.C. reminds investors that a class action 
 lawsuit has been filed in the U.S. District Court for the Southern 
 District of New York on behalf of all persons or entities who purchased 
 or otherwise acquired Neurotrope, Inc. NTRP securities between 
 January 7, 2016 and April 28, 2017 (the "Class Period"). Investors have 
 until July 17, 2017 to apply to the Court to be appointed as lead 
 plaintiff in the lawsuit.
 
 
 The Complaint alleges that throughout the Class Period, Defendants made 
 materially false and misleading statements regarding the efficacy of 
 Bryostatin, a drug that Neurotrope was developing to treat Alzheimer's.
 
 
 On May 1, 2017, Neurotrope issued a press release announcing "positive 
 top-line results" of the pivotal Phase 2b trials of Bryostatin. However, 
 the trial data contradicted Neurotrope's statements, and the top-line 
 data relating to the 20 microgram dose of Bryostatin failed to produce 
 results that were statistically significant. Following this news, shares 
 of Neurotrope fell $11.84, or over 63%, to close at $6.97 per share on 
 May 1, 2017.
 
 
 If you purchased or otherwise acquired Neurotrope securities during the 
 Class Period or continue to hold shares purchased prior to the Class 
 Period, have information, would like to learn more about these claims, 
 or have any questions concerning this announcement or your rights or 
 interests with respect to these matters, please contact Brandon Walker 
 or Melissa Fortunato by email at <a xmlns="http://www.w3.org/1999/xhtml" href="mailto:investigations@bespc.com" rel="nofollow" rel="nofollow">investigations@bespc.com</a>, 
 or telephone at (212) 355-4648, or by <a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fbespc.com%2Fntrp%2F&amp;esheet=51589568&amp;newsitemid=20170714005605&amp;lan=en-US&amp;anchor=filling+out+this+contact+form&amp;index=1&amp;md5=a631c9d3716c5bc0ed7eafbd7dae46dd" rel="nofollow" rel="nofollow">filling 
 out this contact form</a>. There is no cost or obligation to you.
 
 
 Bragar Eagel &amp; Squire, P.C. is a New York-based law firm concentrating 
 in commercial and securities litigation. For additional information 
 concerning the Neurotrope lawsuit, please go to <a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.bespc.com%2Fntrp&amp;esheet=51589568&amp;newsitemid=20170714005605&amp;lan=en-US&amp;anchor=http%3A%2F%2Fwww.bespc.com%2Fntrp&amp;index=2&amp;md5=0a8e005200513b850cf4a5b0621fe9a1" rel="nofollow" rel="nofollow">http://www.bespc.com/ntrp</a>. 
 For additional information about Bragar Eagel &amp; Squire, P.C., please go 
 to <a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.bespc.com&amp;esheet=51589568&amp;newsitemid=20170714005605&amp;lan=en-US&amp;anchor=www.bespc.com&amp;index=3&amp;md5=f9ea435bcec6918fd0235add2e92e276" rel="nofollow" rel="nofollow">www.bespc.com</a>.
 
 
 
 <img xmlns="http://www.w3.org/1999/xhtml" alt="" src="http://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20170714005605r1&amp;sid=benz2&amp;distro=nx&amp;lang=en"></img>View source version on businesswire.com: <a xmlns="http://www.w3.org/1999/xhtml" href="http://www.businesswire.com/news/home/20170714005605/en/" rel="nofollow" rel="nofollow">http://www.businesswire.com/news/home/20170714005605/en/</a></body></html>

Press Releases

Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Neurotrope, Inc. (NTRP) and Encourages Investors with Losses to Contact the Firm Before July 17, 2017 - NextTrip (NASDAQ:NTRP)

NextTrip

NTRP

Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Neurotrope, Inc. (NTRP) and Encourages Investors with Losses to Contact the Firm Before July 17, 2017

BHIL


Benson Hill, Inc. (NYSE:BHIL, the &#34;Company&#34; or &#34;Benson Hill&#34;)), an ag tech company unlocking the natural genetic diversity of plants, announced today that it will release its financial results for the quarter ending

Benson Hill Announces First Quarter Earnings Release Date


Kimball Electronics, Inc. (NASDAQ:KE) today announced that it will report third quarter fiscal year 2024 financial results on Tuesday, May 7, 2024, after the closing of the market. The company will host a conference

Kimball Electronics, Inc. Announces Date For Reporting Third Quarter Fiscal Year 2024 Financial Results


TSMC ((TWSE: 2330, NYSE:TSM) today unveiled its newest semiconductor process, advanced packaging, and 3D IC technologies for powering the next generation of AI innovations with silicon leadership at the Company&#39;s 2024

TSMC Celebrates 30th North America Technology Symposium with Innovations Powering AI with Silicon Leadership


The national survey explores the multi-faceted impact of trees from mental wellness to climate concerns


‘The Canopy Report,&#39; a new consumer report from the Arbor Day Foundation, takes a deep dive into how America sees

Arbor Day Foundation&#39;s &#39;Canopy Report&#39; Examines How America Sees Trees


Streaming everywhere on April 30, see the first in-depth documentary of America&#39;s most unjustly persecuted military hero, General Michael T. Flynn, with additional commentary from Tucker Carlson, Lee Smith, Devin Nunes,

Aquidneck Island Productions, LLC, Under the Esteemed Production of Scott Wiper, Proudly Presents: FLYNN

NSYS


Nortech Systems Incorporated (NASDAQ:NSYS), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical, aerospace &amp; defense and